Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Jouinot

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Virchows Archiv : an International Journal of Pathology|June 22, 2024
PIT-EASY survey: validation of the European Pituitary Pathology Group proposal for reporting pituitary neuroendocrine tumorsMaria Francesca Birtolo, Anne Jouinot, Alexandre Vasiljevic, et al.
Cancers|April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic MelanomaDavid Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
Ebiomedicine|October 23, 2021
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY studyPascaline Boudou-Rouquette, Jennifer Arrondeau, Claire Gervais, et al.
European Journal of Endocrinology|January 22, 2024
Carney complex predisposes to breast cancer: prospective study of 50 womenPatricia Vaduva, Florian Violon, Anne Jouinot, et al.
British Journal of Cancer|February 6, 2026
Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK studyBenoit Blanchet, Alicja Puszkiel, Anne Jouinot, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
European Journal of Endocrinology|December 17, 2025
PRKACA constitutional duplication: a specific cause of primary pigmented nodular adrenocortical diseasePatricia Vaduva, Florian Violon, Albain Chansavang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2025
PDE11A is a phenotype modulator of Primary Bilateral Macronodular Adrenal Hyperplasia: results of a 334 patients' seriesPatricia Vaduva, Lucas Bouys, Anne Jouinot, et al.
Orphanet Journal of Rare Diseases|February 5, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an updateLucas Bouys, Anna Vaczlavik, Isadora P Cavalcante, et al.
Endocrine-Related Cancer|November 5, 2020
Genomic classification of benign adrenocortical lesionsSimon Faillot, Thomas Foulonneau, Mario Néou, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Virchows Archiv : an International Journal of Pathology|June 22, 2024
PIT-EASY survey: validation of the European Pituitary Pathology Group proposal for reporting pituitary neuroendocrine tumorsMaria Francesca Birtolo, Anne Jouinot, Alexandre Vasiljevic, et al.
Cancers|April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic MelanomaDavid Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
Ebiomedicine|October 23, 2021
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY studyPascaline Boudou-Rouquette, Jennifer Arrondeau, Claire Gervais, et al.
European Journal of Endocrinology|January 22, 2024
Carney complex predisposes to breast cancer: prospective study of 50 womenPatricia Vaduva, Florian Violon, Anne Jouinot, et al.
British Journal of Cancer|February 6, 2026
Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK studyBenoit Blanchet, Alicja Puszkiel, Anne Jouinot, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
European Journal of Endocrinology|December 17, 2025
PRKACA constitutional duplication: a specific cause of primary pigmented nodular adrenocortical diseasePatricia Vaduva, Florian Violon, Albain Chansavang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2025
PDE11A is a phenotype modulator of Primary Bilateral Macronodular Adrenal Hyperplasia: results of a 334 patients' seriesPatricia Vaduva, Lucas Bouys, Anne Jouinot, et al.
Orphanet Journal of Rare Diseases|February 5, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an updateLucas Bouys, Anna Vaczlavik, Isadora P Cavalcante, et al.
Endocrine-Related Cancer|November 5, 2020
Genomic classification of benign adrenocortical lesionsSimon Faillot, Thomas Foulonneau, Mario Néou, et al.
Pageof 9